Skip to main content
Jonathan Plehn, MD, Cardiology, Keene, NY

Jonathan Freeman Plehn MD

Heart Failure & Transplantation, Cardiothoracic Imaging, Cardiovascular Disease Genetics, Clinical Pharmacology


Chief Medical Officer, SignPath Pharma

Join to View Full Profile
  • 9 Sky High WayKeene, NY 12942

  • Phone+1 518-912-7434

Dr. Plehn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterFellowship, Cardiovascular Disease, 1981 - 1983
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Cardiovascular Disease, 1980 - 1981
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1978 - 1980
  • UPMC Medical Education
    UPMC Medical EducationInternship, Internal Medicine, 1977 - 1978
  • New York University School of Medicine
    New York University School of MedicineClass of 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2026
  • PA State Medical License
    PA State Medical License 1978 - 2016
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Medera Receives Fda Clearance for a First-in-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction
    Medera Receives Fda Clearance for a First-in-Human Gene Therapy Trial for Heart Failure with Preserved Ejection FractionNovember 18th, 2022
  • Progress in Treating Chronic Kidney Disease Patients with Cardiovascular Disease: Kidney Health Initiative Develops Clinical Research Recommendations
    Progress in Treating Chronic Kidney Disease Patients with Cardiovascular Disease: Kidney Health Initiative Develops Clinical Research RecommendationsFebruary 15th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: